Exact Sciences
EXAS
#1156
Rank
โ‚ฌ16.40 B
Marketcap
86,45ย โ‚ฌ
Share price
0.00%
Change (1 day)
47.86%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.85 Billion

According to Exact Sciences's latest financial reports the company has โ‚ฌ0.85 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.99 B41.8%
2023-12-31โ‚ฌ0.70 B19.38%
2022-12-31โ‚ฌ0.58 B-35.24%
2021-12-31โ‚ฌ0.90 B-39.17%
2020-12-31โ‚ฌ1.49 B417.77%
2019-12-31โ‚ฌ0.28 B-70.6%
2018-12-31โ‚ฌ0.98 B177.62%
2017-12-31โ‚ฌ0.35 B19.68%
2016-12-31โ‚ฌ0.29 B5.38%
2015-12-31โ‚ฌ0.28 B20.72%
2014-12-31โ‚ฌ0.23 B140.94%
2013-12-31โ‚ฌ96.49 M18.05%
2012-12-31โ‚ฌ81.73 M13.7%
2011-12-31โ‚ฌ71.89 M0.22%
2010-12-31โ‚ฌ71.73 M322.45%
2009-12-31โ‚ฌ16.98 M380.83%
2008-12-31โ‚ฌ3.53 M-59.03%
2007-12-31โ‚ฌ8.62 M-46.03%
2006-12-31โ‚ฌ15.97 M-44.55%
2005-12-31โ‚ฌ28.8 M-22.29%
2004-12-31โ‚ฌ37.06 M67.82%
2003-12-31โ‚ฌ22.08 M-47.34%
2002-12-31โ‚ฌ41.94 M-34.83%
2001-12-31โ‚ฌ64.36 M129.07%
2000-12-31โ‚ฌ28.09 M695.73%
1999-12-31โ‚ฌ3.53 M-52.52%
1998-12-31โ‚ฌ7.43 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Myriad Genetics
MYGN
โ‚ฌ0.12 B-85.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚ฌ0.31 B-63.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚ฌ5.66 M-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ8.92 B 941.97%๐Ÿ‡ซ๐Ÿ‡ท France